2010 FDA Medical Pharmaceutical products 
European Pharmaceutical Review
MARCH 11, 2024
In a review on fungal-contaminated compounded pharmaceuticals and medical devices, researchers have described how the contamination of these products can be due to breaches in sterile compounding procedures. Ahmed et al. One case of drug contamination from 2021 was highlighted in the paper.
pharmaphorum
JULY 27, 2022
The paper, by a team from Imperial College London, concluded that the FDA gave the go ahead to 95% of the 89 products approved between 2010 and 2019 before EMA, with the Europeans trailing the Americans by a median of 241 days. Amanda Barrell is a freelance health and medical education journalist, editor and copywriter.
Expert insights. Personalized for you.
82 
Let's personalize your content